Status
Conditions
Treatments
About
Project RESET is a Singapore National Medical Research Council Large Collaborative Grant funded program that brings together a nationwide community of cardiovascular, metabolic, and digital health researchers, as well as clinicians across primary and tertiary care to study the immune, lipid and metabolic drivers of early cardiovascular disease. RESET incorporates a nested randomised controlled trials (RCT) to test the use of a combined digital wearable and AI-human symbiotic lifestyle intervention to halt or reverse the progression of early disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
3,000 participants in 2 patient groups
Loading...
Central trial contact
Hayang Yang, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal